These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 11179780)

  • 21. Opposing effects of androgen and estrogen on pituitary-adrenal function in nonpregnant primates.
    Giussani DA; Farber DM; Jenkins SL; Yen A; Winter JA; Tame JD; Nathanielsz PW
    Biol Reprod; 2000 May; 62(5):1445-51. PubMed ID: 10775199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arginine vasopressin and corticotropin releasing factor: binding to ovine anterior pituitary membranes.
    Shen PJ; Clarke IJ; Canny BJ; Funder JW; Smith AI
    Endocrinology; 1990 Nov; 127(5):2085-9. PubMed ID: 2226302
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ontogeny of corticotropin-releasing factor and arginine vasopressein in the rat.
    Rundle SE; Funder JW
    Neuroendocrinology; 1988 May; 47(5):374-8. PubMed ID: 3260999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuropeptide cells and fibers in the hypothalamus and pituitary of the fetal sheep: comparison of oxytocin and arginine vasopressin.
    Hoffman GE; McDonald T; Figueroa JP; Nathanielsz PW
    Neuroendocrinology; 1989 Dec; 50(6):633-43. PubMed ID: 2515463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of ovine fetal pituitary function by corticotrophin-releasing hormone, arginine vasopressin and cortisol in vitro.
    Lü F; Yang K; Challis JR
    J Endocrinol; 1994 Oct; 143(1):199-208. PubMed ID: 7964318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adrenocorticotropin secretion by fetal sheep anterior and intermediate lobe pituitary cells in vitro: effects of gestation and adrenalectomy.
    Fora MA; Butler TG; Rose JC; Schwartz J
    Endocrinology; 1996 Aug; 137(8):3394-400. PubMed ID: 8754766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential regulation of corticotropin-releasing factor and vasopressin in discrete brain regions after morphine administration: correlations with hypothalamic noradrenergic activity and pituitary-adrenal response.
    Milanés MV; Laorden ML; Chapleur-Château M; Burlet A
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Nov; 356(5):603-10. PubMed ID: 9402040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effects of estrogen and progesterone on corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid levels in the paraventricular nucleus and supraoptic nucleus of the rhesus monkey.
    Roy BN; Reid RL; Van Vugt DA
    Endocrinology; 1999 May; 140(5):2191-8. PubMed ID: 10218971
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cocaine- and amphetamine-regulated transcript activates the hypothalamic-pituitary-adrenal axis through a corticotropin-releasing factor receptor-dependent mechanism.
    Smith SM; Vaughan JM; Donaldson CJ; Rivier J; Li C; Chen A; Vale WW
    Endocrinology; 2004 Nov; 145(11):5202-9. PubMed ID: 15271883
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hypothalamic-pituitary-adrenal axis activity and its relationship to the autonomic nervous system in women with visceral and subcutaneous obesity: effects of the corticotropin-releasing factor/arginine-vasopressin test and of stress.
    Pasquali R; Anconetani B; Chattat R; Biscotti M; Spinucci G; Casimirri F; Vicennati V; Carcello A; Labate AM
    Metabolism; 1996 Mar; 45(3):351-6. PubMed ID: 8606643
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of sex steroids on the degradation of LRH by hypothalamic homogenates.
    Tate AC; Swift AD
    Acta Endocrinol (Copenh); 1981 Nov; 98(3):321-5. PubMed ID: 6457495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ghrelin stimulates corticotropin-releasing factor and vasopressin gene expression in rat hypothalamic 4B cells.
    Kageyama K; Kumata Y; Akimoto K; Takayasu S; Tamasawa N; Suda T
    Stress; 2011 Sep; 14(5):520-9. PubMed ID: 21438782
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The response of hypothalamic CRF and AVP neurons of neonatal rats to simulated acute hypoxia].
    Yang SM; Du JZ
    Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2005 Nov; 21(4):419-22. PubMed ID: 21180163
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of excitatory amino acid transmitters on hypothalamic corticotropin-releasing hormone (CRH) and arginine-vasopressin (AVP) release in vitro: implications in pituitary-adrenal regulation.
    Patchev VK; Karalis K; Chrousos GP
    Brain Res; 1994 Jan; 633(1-2):312-6. PubMed ID: 7907936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controls of corticotrophin-releasing factor output by hypothalamic tissue from fetal sheep in vitro.
    Brooks AN; Power LA; Jones SA; Yang KP; Challis JR
    J Endocrinol; 1989 Jul; 122(1):15-22. PubMed ID: 2788695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of hypothalamic arginine vasopressin messenger ribonucleic acid and pituitary arginine vasopressin content in fetal sheep: effects of acute tonicity alterations and fetal maturation.
    Zhao X; Nijland MJ; Ervin MG; Ross MG
    Am J Obstet Gynecol; 1998 Oct; 179(4):899-905. PubMed ID: 9790367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of arginine vasopressin and corticotropin-releasing factor in mediating alcohol-induced adrenocorticotropin and vasopressin secretion in male rats bearing lesions of the paraventricular nuclei.
    Ogilvie KM; Lee S; Rivier C
    Brain Res; 1997 Jan; 744(1):83-95. PubMed ID: 9030416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin.
    Mozid AM; Tringali G; Forsling ML; Hendricks MS; Ajodha S; Edwards R; Navarra P; Grossman AB; Korbonits M
    Horm Metab Res; 2003 Aug; 35(8):455-9. PubMed ID: 12953161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased plasma concentrations, hypothalamic content, and in vitro release of arginine vasopressin in inflammatory disease-prone, hypothalamic corticotropin-releasing hormone-deficient Lewis rats.
    Patchev VK; Kalogeras KT; Zelazowski P; Wilder RL; Chrousos GP
    Endocrinology; 1992 Sep; 131(3):1453-7. PubMed ID: 1505475
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies of the secretion of corticotropin-releasing factor and arginine vasopressin into the hypophysial-portal circulation of the conscious sheep. II. The central noradrenergic and neuropeptide Y pathways cause immediate and prolonged hypothalamic-pituitary-adrenal activation. Potential involvement in the pseudo-Cushing's syndrome of endogenous depression and anorexia nervosa.
    Liu JP; Clarke IJ; Funder JW; Engler D
    J Clin Invest; 1994 Apr; 93(4):1439-50. PubMed ID: 8163648
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.